Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug discovery
Podcast
What Xaira is building after its $1B fundraise
Xaira COO Jeff Jonker joins "The Top Line" to talk strategy, AI and the company’s long-game vision for drug discovery.
Ayla Ellison
,
Gabrielle Masson
Mar 20, 2026 10:34am
Astellas ends $1.6B biobucks TCE pact with CytomX after 6 years
Mar 16, 2026 10:12am
RoukenBio, AVS Bio partner for predictable antibody development
Feb 17, 2026 3:45pm
CRO Sygnature Discovery plans to send 60 UK staffers packing
Jan 30, 2026 5:00pm
Chugai drops only AI-assisted antibody from pipeline
Jan 30, 2026 10:55am
Lilly joins platform biotech's Repertoire with $1.9B deal
Jan 29, 2026 6:30am
